Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities

Carlos A. Reyes-Ortiz, Luis F. Velez, Maria Hughes, Kenneth Ottenbacher, Kyriakos Markides

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: The purpose of this study is to describe the prevalence of Papanicolaou (Pap) smear use for cervical cancer screening and to estimate its association with type of health care insurance. Methods: Across-sectional study using data from the Health, Well-Being and Aging in Latin America and the Caribbean Study (SABE). The sample includes 6357 women aged 60 and older from seven cities. The outcome was reporting a Pap smear for cervical cancer screening during the previous 2 years. Main independent variable was health care insurance. Covariates were demographic or socioeconomic variables, medical conditions and functional status. Results: Prevalence of Pap smear use across the seven cities ranged from 21% in Bridgetown to 45% in Mexico City. In a multivariate analysis of the combined sample, without Havana that has universal health care insurance, women with public insurance (OR 0.55, 95% CI 0.43 - 0.71) or with no insurance (OR 0.23, 95% CI 0.15 - 0.34) were less likely to have a Pap smear compared with women with private insurance. Also, women with no insurance were less likely to have a Pap smear (OR 0.40, 95% CI 0.30 - 0.54) compared with women with any health insurance. Conclusions: In general, the prevalence of Pap smear use was lower than that reported for Hispanic populations in the United States. Overall, lack of health insurance or having public health insurance determined lower odds for having a Pap smear for cervical cancer screening.

Original languageEnglish (US)
Pages (from-to)870-878
Number of pages9
JournalInternational Journal of Epidemiology
Volume37
Issue number4
DOIs
StatePublished - Aug 2008

Fingerprint

Health Insurance
Papanicolaou Test
Early Detection of Cancer
Uterine Cervical Neoplasms
Insurance
Delivery of Health Care
Latin America
Mexico
Hispanic Americans
Multivariate Analysis
Public Health
Demography
Health

Keywords

  • Cancer screening
  • Health insurance
  • Latin America and Caribbean
  • Older women
  • Pap smear

ASJC Scopus subject areas

  • Epidemiology

Cite this

Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities. / Reyes-Ortiz, Carlos A.; Velez, Luis F.; Hughes, Maria; Ottenbacher, Kenneth; Markides, Kyriakos.

In: International Journal of Epidemiology, Vol. 37, No. 4, 08.2008, p. 870-878.

Research output: Contribution to journalArticle

@article{f52dcd720f4b47178ae10edf21e0f0d8,
title = "Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities",
abstract = "Background: The purpose of this study is to describe the prevalence of Papanicolaou (Pap) smear use for cervical cancer screening and to estimate its association with type of health care insurance. Methods: Across-sectional study using data from the Health, Well-Being and Aging in Latin America and the Caribbean Study (SABE). The sample includes 6357 women aged 60 and older from seven cities. The outcome was reporting a Pap smear for cervical cancer screening during the previous 2 years. Main independent variable was health care insurance. Covariates were demographic or socioeconomic variables, medical conditions and functional status. Results: Prevalence of Pap smear use across the seven cities ranged from 21{\%} in Bridgetown to 45{\%} in Mexico City. In a multivariate analysis of the combined sample, without Havana that has universal health care insurance, women with public insurance (OR 0.55, 95{\%} CI 0.43 - 0.71) or with no insurance (OR 0.23, 95{\%} CI 0.15 - 0.34) were less likely to have a Pap smear compared with women with private insurance. Also, women with no insurance were less likely to have a Pap smear (OR 0.40, 95{\%} CI 0.30 - 0.54) compared with women with any health insurance. Conclusions: In general, the prevalence of Pap smear use was lower than that reported for Hispanic populations in the United States. Overall, lack of health insurance or having public health insurance determined lower odds for having a Pap smear for cervical cancer screening.",
keywords = "Cancer screening, Health insurance, Latin America and Caribbean, Older women, Pap smear",
author = "Reyes-Ortiz, {Carlos A.} and Velez, {Luis F.} and Maria Hughes and Kenneth Ottenbacher and Kyriakos Markides",
year = "2008",
month = "8",
doi = "10.1093/ije/dyn096",
language = "English (US)",
volume = "37",
pages = "870--878",
journal = "International Journal of Epidemiology",
issn = "0300-5771",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities

AU - Reyes-Ortiz, Carlos A.

AU - Velez, Luis F.

AU - Hughes, Maria

AU - Ottenbacher, Kenneth

AU - Markides, Kyriakos

PY - 2008/8

Y1 - 2008/8

N2 - Background: The purpose of this study is to describe the prevalence of Papanicolaou (Pap) smear use for cervical cancer screening and to estimate its association with type of health care insurance. Methods: Across-sectional study using data from the Health, Well-Being and Aging in Latin America and the Caribbean Study (SABE). The sample includes 6357 women aged 60 and older from seven cities. The outcome was reporting a Pap smear for cervical cancer screening during the previous 2 years. Main independent variable was health care insurance. Covariates were demographic or socioeconomic variables, medical conditions and functional status. Results: Prevalence of Pap smear use across the seven cities ranged from 21% in Bridgetown to 45% in Mexico City. In a multivariate analysis of the combined sample, without Havana that has universal health care insurance, women with public insurance (OR 0.55, 95% CI 0.43 - 0.71) or with no insurance (OR 0.23, 95% CI 0.15 - 0.34) were less likely to have a Pap smear compared with women with private insurance. Also, women with no insurance were less likely to have a Pap smear (OR 0.40, 95% CI 0.30 - 0.54) compared with women with any health insurance. Conclusions: In general, the prevalence of Pap smear use was lower than that reported for Hispanic populations in the United States. Overall, lack of health insurance or having public health insurance determined lower odds for having a Pap smear for cervical cancer screening.

AB - Background: The purpose of this study is to describe the prevalence of Papanicolaou (Pap) smear use for cervical cancer screening and to estimate its association with type of health care insurance. Methods: Across-sectional study using data from the Health, Well-Being and Aging in Latin America and the Caribbean Study (SABE). The sample includes 6357 women aged 60 and older from seven cities. The outcome was reporting a Pap smear for cervical cancer screening during the previous 2 years. Main independent variable was health care insurance. Covariates were demographic or socioeconomic variables, medical conditions and functional status. Results: Prevalence of Pap smear use across the seven cities ranged from 21% in Bridgetown to 45% in Mexico City. In a multivariate analysis of the combined sample, without Havana that has universal health care insurance, women with public insurance (OR 0.55, 95% CI 0.43 - 0.71) or with no insurance (OR 0.23, 95% CI 0.15 - 0.34) were less likely to have a Pap smear compared with women with private insurance. Also, women with no insurance were less likely to have a Pap smear (OR 0.40, 95% CI 0.30 - 0.54) compared with women with any health insurance. Conclusions: In general, the prevalence of Pap smear use was lower than that reported for Hispanic populations in the United States. Overall, lack of health insurance or having public health insurance determined lower odds for having a Pap smear for cervical cancer screening.

KW - Cancer screening

KW - Health insurance

KW - Latin America and Caribbean

KW - Older women

KW - Pap smear

UR - http://www.scopus.com/inward/record.url?scp=48349133493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48349133493&partnerID=8YFLogxK

U2 - 10.1093/ije/dyn096

DO - 10.1093/ije/dyn096

M3 - Article

C2 - 18511488

AN - SCOPUS:48349133493

VL - 37

SP - 870

EP - 878

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

SN - 0300-5771

IS - 4

ER -